<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="jia225610-sup-0001">
 <caption>
  <p>
   <bold>Figure S1.</bold> Definition of non‐retention.
  </p>
  <p>
   <bold>Figure S2.</bold> Definition of viral suppression.
  </p>
  <p>
   <bold>Figure S3.</bold> Kaplan‐Meier curves for viral suppression. (a) all participants, (b) SoC ineligible and (c) SoC eligible.
  </p>
  <p>
   <bold>Figure S4.</bold> Kaplan‐Meier curves for combined endpoint, retention and viral suppression. (a) all participants, (b) above SoC and (c) under SoC participants.
  </p>
  <p>
   <bold>Figure S5.</bold> Forest plot of the intervention effect modification for retention, by covariates.
  </p>
  <p>
   <bold>Figure S6.</bold> Forest plot of the intervention effect modification for retention, by covariates.
  </p>
  <p>
   <bold>Figure S7.</bold> Forest plot of the intervention effect modification for viral suppression, by covariates.
  </p>
  <p>
   <bold>Figure S8.</bold> Forest plot of the intervention effect modification for the combined endpoint, by covariates
  </p>
  <p>
   <bold>Talbe S1.</bold> Effect of EAAA on retention among all participants, by pre‐specified subgroups.
  </p>
  <p>
   <bold>Table S2.</bold> Effect of EAAA on viral suppression six months or more after ART initiation among all participants retained to ART initiation, by pre‐specified subgroups
  </p>
  <p>
   <bold>Table S3.</bold> Effect of EAAA on retention and viral suppression among all participants, by pre‐specified subgroups
  </p>
 </caption>
 <media xlink:href="JIA2-23-e25610-s001.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption>
   <p>Click here for additional data file.</p>
  </caption>
 </media>
</supplementary-material>
